Top Marijuana Stocks in the NASDAQ
Posted in : Shop Cbd Oildiscount on by : Melillo
Even though greater part of U.S.-based cannabis organizations and many foreign American Depository Receipts (ADRs) trade within the counter (OTC), a marijuana that is few are exchanged regarding the NASDAQ. Some investors choose shares which can be noted on the NASDAQ to many other exchanges for their increased liquidity and tighter spreads when compared to over-the-counter markets. As an example, since the cannabis industry has exploded in present months and years, uplisting from an OTC market to an established U.S. trade is now an advertising achievement for a lot of marijuana that is rising. (For related reading, see “Understanding Medical Cannabis vs. Recreational Cannabis Stocks”)
An increasing quantity of cannabis businesses are increasingly being noted on reputable U.S. exchanges instead of being exchanged regarding the OTC market showing the fast development of the cannabis industry.
NASDAQ-listed Marijuana shares
The NASDAQ ended up being the initial exchange that is electronic is definitely similar to technology and biotechnology. The cannabis companies in the NASDAQ reflect this, additionally the most of them operate into the area that is biotech of industry. Here you will find the marijuana that is NASDAQ-listed, in alphabetical order, at the time of October 26, 2019, with a dysfunction of these total returns.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals is really a biotech company active in the production of medical cannabis drugs. Research and development around Arena’s APD371 could be the main focus associated with the firm’s cannabis biotech initiatives.
Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)
Atlantic Alliance Partnership Corp. is really a check that is blank that is currently in a merger contract with Kalyx developing Inc. Kalyx is a number one real estate investment rely upon the regulated cannabis industry in america.
- The cannabis industry, specially the area of marijuana and biotech, is attracting substantial investor attention.
- Cannabis will be found in brand brand new medications to treat discomfort and numerous chronic, inflammatory, and fibrotic conditions.
- Organizations will also be developing cannabinoid services and products for autism spectrum problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (a genetic condition), and addiction that is amphetamine.
Cara Therapeutics Inc. (NASDAQ:CARA)
Cara Therapeutics is a clinical-stage biotechnology business focused on developing and commercializing chemical that is new for the indications of pain and pruritus (itching). Although all the company’s clinical-stage services and products target opioid receptors, Cara happens to be performing preclinical research on cannabinoids to treat neuropathic discomfort.
Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)
Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech company. The team’s research, development, and production are based around cannabis medications that look for to deal with chronic, inflammatory, fibrotic, along with other conditions.
Cronos Group Inc. (NASDAQ:CRON)
Cronos Group Inc. is really A canadian cannabis business. The group has and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro maker Altria announced plans to spend $1.8 billion in Cronos. The investment has provided Cronos not just with extra cash to fund its continued expansion but in addition with a well-established partner skilled into the marketing of consumer brands.
Greenlane Holdings Inc. (NASDAQ:GNLN)
Greenlane Holdings Inc. is just a Boca Raton, Florida-based cannabis business. It distributes a number of cannabis usage accessories and vaporization gear and items to retail clients in the U.S. and Canada. Also, it runs e-commerce web sites for extra product product sales.
GW Pharmaceuticals Plc. (NASDAQ:GWPH)
GW Pharmaceuticals is developing a profile of cannabinoid medications. These medicines consist of Sativex for the treatment of spasticity pertaining to sclerosis that is multiple cancer tumors discomfort and Epidiolex for the treatment of youth epilepsy. Sativex is commercialized much more compared to a dozen nations away from united states of america and has now gotten approval that is regulatory some other nations. Epidiolex received Food And Drug Administration approval as a treatment plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two kinds of serious, early beginning epilepsy without good current treatment options. Other indications reveal that GW Pharmaceuticals is developing cannabinoid items for autism spectrum problems, schizophrenia, and glioma.
Intec Pharma Ltd. (NASDAQ:NTEC)
Intec Pharma is a clinical-stage biopharmaceutical business that is developing medications predicated on its proprietary Accordion Pill technology. Intec’s item pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.
Marrone Bio Innovations, Inc. (NASDAQ:MBII)
Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based pest administration and plant health items. In 2017, Marrone Bio Innovations announced that three MBII ingredients that are active now legal to be used on cannabis crops into the Ca cultivation market.
Modern Age Beverages Corp. (NASDAQ:NBEV)
Modern age Beverages Corp. is a maker of beverages produced from yerba mate, green tea leaf, kombucha, and comparable services and products. In current months, modern age has expanded its beverage offerings to add CBD infusions too, bringing it to the orbit of cannabis shares.
OrganiGram Holdings Inc. (NASDAQ:OGI)
Canadian cannabis producer OrganiGram Holdings Inc. debuted from the NASDAQ in might of 2019, which makes it probably one of the most present cannabis businesses to record in the popular trade. The business happens to be quickly expanding its production ability and may also have the ability to create up to 113,000 kilograms of item per by the end of 2019 year.
Psychemedics Corporation (NASDAQ:PMD)
Psychemedics Corporation runs within the enforcement sector. The company’s business operations support medication assessment through hair examples.
Sundial Growers Inc. (NASDAQ:SNDL)
Alberta, Canada-based Sundial Growers Inc. is yet another entry that is new the NASDAQ trade. The cannabis producer made headlines in October of 2019 (and saw a price that is brief) when it announced the production of an innovative new Palmetto make of leisure cannabis, first for sale in Saskatchewan and Manitoba.
Therapix Biosciences Ltd. (NASDAQ:TRPX)
Therapix Biosciences Ltd. is pure cbd oil for sale a specialty clinical-stage company that is pharmaceutical in the growth of cannabinoid-based medications. Therapix’s present pipeline includes services and products targeted to treat Tourette syndrome and mild impairment that is cognitive.
Tilray Inc. (NASDAQ:TLRY)
Tilray Inc. had been the very first marijuana-related business to have a short public providing (IPO) in america. The Nanaimo, Vancouver Island-based company concentrates on medical cannabis items.
Village Farms Global (NASDAQ:VFF)
Village Farms Global is one of present cannabis stock to begin investing from the NASDAQ. The business’s stocks became readily available for trade on 21, 2019 february. The organization possesses history that is decades-long greenhouse produce manufacturing and contains just recently shifted several of its focus toward cannabis production.
Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)
Zynerba Pharmaceuticals is targeted from the growth of synthetic treatments that are cannabinoid transdermal (through skin) delivery. Their pipeline presently includes two drugs being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic pain, and Fragile X syndrome.